NIH-funded research NIH-funded research

New method for making CAR-T cells quickly and efficiently

Official title: MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cells

Funded at Univ of North Carolina Chapel Hill · NIH-10909190 · Data updated 2026-11-12

This study is testing a new way to make CAR-T cells faster and cheaper for cancer treatment, using special tools to help speed up the process, so patients can get their therapy sooner and hopefully see better results.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 17, 2023
Project endJuly 31, 2027
Funding year2023
Award (this year)$261,931
NIH project number7R33CA281875-02
Project IDNIH-10909190 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who require CAR-T cell therapy for aggressive cancers and are facing delays in treatment.

Less likely to help

Patients who do not require CAR-T cell therapy or those with conditions not addressed by this treatment may not benefit from this research.

What this research studies

This research focuses on improving the production of CAR-T cells, which are used in cancer treatment. The current manufacturing process is lengthy and costly, often delaying treatment for patients with aggressive diseases. The study introduces a novel technology called MASTER, which uses specialized scaffolds to streamline the CAR-T cell production process. By implanting these scaffolds with patient cells, the research aims to simplify and speed up the creation of CAR-T cells, potentially enhancing their effectiveness.

Why it matters

Potential benefit: If successful, this research could lead to faster and more affordable CAR-T cell therapies for patients with cancer.

How similar studies have gone: While CAR-T cell therapy has shown significant success, the MASTER technology represents a novel approach that has not been widely tested in clinical settings.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Brudno, Yevgeny — Univ of North Carolina Chapel Hill
  • Study coordinator: Brudno, Yevgeny

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.